AAA March 2013 – Page 3

Zalora fashions its $25m

Germany-based retail group Tengelmann’s corporate venturing unit has made its third online fashion investment incubated at Rocket Internet in as many months by backing Singapore-based Zalora. Zalora said it had raised €20m ($25m), while Tengelmann has previously invested in Lazada and Linio. Founded last year, Zalora in September raised “significant double digit millions” of dollars… Continue reading Zalora fashions its $25m

EyeTechCare sounds out $13m

EyeTechCare, a France-based company developing medical devices for eyes, has raised €10m ($13m) in its series C round from a consortium including local insurer Sham. The other investors included venture capital firm Omnes Capital, which was formerly known Credit Agricole Private Equity (Cape) until it spun off from the eponymous bank, and angel investor Bernard… Continue reading EyeTechCare sounds out $13m

BriefCam views its $6.5m

Motorola Solutions Venture Capital, the corporate venturing unit of the eponymous phone equipment maker, has led a $6.5m round in BriefCam, an Israel-based developer of software to analyse surveillance video, according to news provider Globes. Founded in December 2007, in March 2009 BriefCam raised $2.6m in its series A round led by Aviv Venture Capital… Continue reading BriefCam views its $6.5m

Aveillant spots $10m

Aveillant, a UK-based provider of technology to prevent wind turbines affecting airport radar, has raised £6.75m ($10m) from a consortium including Ireland-based utility ESB’s corporate venturing unit. Alongside Greencoat Capital, which manages the €200m ($250m) ESB Novusmodus clean-tech fund, were venture capital firm DFJ Esprit and local advisers Cambridge Consultants. Aveillant spun out from Cambridge… Continue reading Aveillant spots $10m

Mesoblast raises A$170m

Mesoblast, an Australia-listed regenerative medicine company, has raised A$170m ($150m) in a private placement of shares including to its “existing strategic investors”. Under the placement, 27 million ordinary shares, 9.4%, were issued at A$6.30 each, a discount of 2.2% to the closing price of the company’s shares on 1 March.  However, Mesoblast’s spokeswoman by email… Continue reading Mesoblast raises A$170m